Iron Gate Global Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $332K | Hold |
5,760
| – | – | 0.03% | 73 |
|
|
2026
Q1 | $349K | Sell |
5,760
-31
| -0.5% | -$1.81K | 0.04% | 70 |
|
|
2025
Q4 | $312K | Buy |
5,791
+31
| +0.5% | +$1.49K | 0.03% | 74 |
|
|
2025
Q3 | $260K | Hold |
5,760
| – | – | 0.03% | 90 |
|
|
2025
Q2 | $267K | Hold |
5,760
| – | – | 0.03% | 69 |
|
|
2025
Q1 | $351K | Hold |
5,760
| – | – | 0.05% | 61 |
|
|
2024
Q4 | $326K | Sell |
5,760
-136
| -2% | -$7.6K | 0.05% | 64 |
|
|
2024
Q3 | $305K | Hold |
5,896
| – | – | 0.05% | 67 |
|
|
2024
Q2 | $245K | Hold |
5,896
| – | – | 0.04% | 80 |
|
|
2024
Q1 | $314K | Sell |
5,896
-80
| -1% | -$4.08K | 0.06% | 74 |
|
|
2023
Q4 | $307K | Buy |
5,976
+80
| +1% | +$4.2K | 0.06% | 73 |
|
|
2023
Q3 | $343K | Sell |
5,896
-40
| -0.7% | -$2.45K | 0.08% | 62 |
|
|
2023
Q2 | $380K | Hold |
5,936
| – | – | 0.08% | 60 |
|
|
2023
Q1 | $411K | Buy |
5,936
+40
| +0.7% | +$2.82K | 0.1% | 56 |
|
|
2022
Q4 | $424K | Hold |
5,896
| – | – | 0.12% | 52 |
|
|
2022
Q3 | $419K | Buy |
5,896
+1
| +0% | +$73 | 0.12% | 52 |
|
|
2022
Q2 | $453K | Sell |
5,895
-23
| -0.4% | -$1.75K | 0.12% | 56 |
|
|
2022
Q1 | $432K | Buy |
5,918
+1
| +0% | +$67 | 0.1% | 64 |
|
|
2021
Q4 | $367K | Hold |
5,917
| – | – | 0.09% | 71 |
|
|
2021
Q3 | $350K | Sell |
5,917
-158
| -3% | -$10.4K | 0.09% | 74 |
|
|
2021
Q2 | $405K | Buy |
6,075
+315
| +5% | +$20.5K | 0.11% | 71 |
|
|
2021
Q1 | $363K | Hold |
5,760
| – | – | 0.12% | 73 |
|
|
2020
Q4 | $357K | Hold |
5,760
| – | – | 0.13% | 65 |
|
|
2020
Q3 | $347K | Hold |
5,760
| – | – | 0.15% | 66 |
|
|
2020
Q2 | $339K | Hold |
5,760
| – | – | 0.16% | 59 |
|
|
2020
Q1 | $321K | Hold |
5,760
| – | – | 0.22% | 44 |
|
|
2019
Q4 | $370K | Hold |
5,760
| – | – | 0.21% | 46 |
|
|
2019
Q3 | $292K | Hold |
5,760
| – | – | 0.18% | 55 |
|
|
2019
Q2 | $261K | Hold |
5,760
| – | – | 0.17% | 54 |
|
|
2019
Q1 | $272K | Hold |
5,760
| – | – | 0.11% | 59 |
|
|
2018
Q4 | $299K | Hold |
5,760
| – | – | 0.22% | 45 |
|
|
2018
Q3 | $303K | Buy |
5,760
+5,710
| +11,420% | +$339K | 0.2% | 44 |
|
|
2018
Q2 | $3K | Buy |
+50
| New | +$2.7K | ﹤0.01% | 185 |
|
Other funds holding BMY
Iron Gate Global Advisors's BMY Position: Q2 2026 in Review
Iron Gate Global Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 5,760 shares worth $332K. The position accounts for 0.03% of the portfolio, ranked #73.
Iron Gate Global Advisors first reported a position in BMY in Q2 2018 and has held it in 33 quarters since. The position peaked at $453K in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Iron Gate Global Advisors held 5,760 shares of Bristol-Myers Squibb worth $332K as of Q2 2026.
- Iron Gate Global Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.03% of Iron Gate Global Advisors's portfolio in Q2 2026, its #73 holding.
- Iron Gate Global Advisors first reported a position in Bristol-Myers Squibb in Q2 2018 and has held it in 33 quarters since.
- Iron Gate Global Advisors's Bristol-Myers Squibb position peaked at $453K in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Iron Gate Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.